3D Printed Multi-Functional Scaffolds Based on Poly(ε-Caprolactone) and Hydroxyapatite Composites.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Orthopedic Research

Background:

• Biodegradable polymeric scaffolds are essential for bone defect repair, offering microenvironments for cell attachment and regeneration.
• Poly(ε-caprolactone) (PCL) and hydroxyapatite (HA) composites offer promising properties for bone tissue engineering.

Purpose of the Study:

• To develop and evaluate 3D printed PCL/HA composite scaffolds for bone defect repair.
• To assess the biocompatibility, biodegradability, and bone regenerative potential of these scaffolds.
• To investigate the feasibility of incorporating doxorubicin (DOX) for enhanced bone repair and potential anti-tumor effects.

Main Methods:

• Preparation of biodegradable PCL/HA composites.
• Fabrication of PCL/HA scaffolds using melting deposition-forming (3D printing).
• In vitro assessments including biodegradability, cytotoxicity, and cell proliferation (MC3T3-E1 osteoblast cells).
• In vivo studies using rat and rabbit bone defect models.

Main Results:

• PCL/HA composites exhibited good biodegradability, low cytotoxicity, and enhanced osteoblast cell proliferation.
• In vivo experiments demonstrated scaffold adhesion and penetration by bone cells, leading to bone tissue regeneration.
• 3D printed PCL/HA/DOX scaffolds showed sustained drug release, enhancing bone repair and potentially inhibiting tumor cells.

Conclusions:

• 3D printed PCL/HA composite scaffolds are effective for bone defect repair, promoting cell growth and tissue regeneration.
• The incorporation of doxorubicin offers a multifunctional approach for enhanced bone repair and potential adjuvant cancer therapy.
• PCL/HA composites represent a promising class of biodegradable materials for orthopedic applications.